Log In
BCIQ
Print this Print this
 

Irino, ironotecan

  Manage Alerts
Collapse Summary General Information
Company TTY Biopharm Co. Ltd.
Description20 mg irinotecan
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today